{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:10:08Z","timestamp":1765825808967,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00345-020-03118-x","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:06:47Z","timestamp":1581937607000},"page":"3183-3190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort"],"prefix":"10.1007","volume":"38","author":[{"given":"Tomohisa","family":"Matsunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-1929","authenticated-orcid":false,"given":"Kazumasa","family":"Komura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayahito","family":"Nomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"issue":"1","key":"3118_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3118_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E et al (2018) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"8","key":"3118_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.7150\/jca.7326","volume":"4","author":"TS Kim","year":"2013","unstructured":"Kim TS, Oh JH, Rhew HY (2013) The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma. J Cancer 4(8):686\u2013690","journal-title":"J Cancer"},{"doi-asserted-by":"crossref","unstructured":"Fujita K, Taneishi K, Inamoto T et al (2017) Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis. BMC Urol 17(1):110","key":"3118_CR4","DOI":"10.1186\/s12894-017-0305-4"},{"issue":"10","key":"3118_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00345-017-2032-6","volume":"35","author":"T Nakagawa","year":"2017","unstructured":"Nakagawa T, Komemushi Y, Kawai T et al (2017) Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study. World J Urol 35(10):1569\u20131575","journal-title":"World J Urol"},{"issue":"11","key":"3118_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/iju.12868","volume":"22","author":"K Fujita","year":"2015","unstructured":"Fujita K, Inamoto T, Yamamoto Y et al (2015) Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: a multi-institutional, retrospective study. Int J Urol 22(11):1006\u20131012","journal-title":"Int J Urol"},{"issue":"5","key":"3118_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.urolonc.2016.11.017","volume":"35","author":"GE Gin","year":"2017","unstructured":"Gin GE, Ruel NH, Kardos SV et al (2017) Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma. Urol Oncol 35(5):192\u2013200","journal-title":"Urol Oncol"},{"issue":"3","key":"3118_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","volume":"182","author":"NJ Hellenthal","year":"2009","unstructured":"Hellenthal NJ, Shariat SF, Margulis V et al (2009) Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 182(3):900\u2013906","journal-title":"J Urol"},{"issue":"1","key":"3118_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","volume":"68","author":"C Kwak","year":"2006","unstructured":"Kwak C, Lee SE, Jeong IG, Ku JH (2006) Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68(1):53\u201357","journal-title":"Urology"},{"issue":"2","key":"3118_CR10","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.18632\/oncotarget.12239","volume":"8","author":"X Yang","year":"2017","unstructured":"Yang X, Li P, Deng X et al (2017) Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis. Oncotarget 8(2):3568\u20133580","journal-title":"Oncotarget"},{"issue":"8","key":"3118_CR11","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J et al (2017) Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol 35(8):852\u2013860","journal-title":"J Clin Oncol"},{"issue":"2","key":"3118_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bju.14020","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi A, Lo Vullo S, Mariani L et al (2018) Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 121(2):252\u2013259","journal-title":"BJU Int"},{"issue":"11","key":"3118_CR13","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s00432-019-03020-z","volume":"145","author":"SH Song","year":"2019","unstructured":"Song SH, Ye CH, Lee S et al (2019) Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy. J Cancer Res Clin Oncol 145(11):2863\u20132870","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3118_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57(6):1064\u20131071","journal-title":"Eur Urol"},{"issue":"4","key":"3118_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","volume":"27","author":"E Kikuchi","year":"2009","unstructured":"Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27(4):612\u2013618","journal-title":"J Clin Oncol"},{"doi-asserted-by":"crossref","unstructured":"Birtle AJ, Chester JD, Jones RJ et al (2018) Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). J Clin Oncol 36(6_suppl):407\u2013407","key":"3118_CR16","DOI":"10.1200\/JCO.2018.36.6_suppl.407"},{"issue":"20","key":"3118_CR17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194","journal-title":"JAMA"},{"issue":"12","key":"3118_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1756287218811050","volume":"10","author":"T Inamoto","year":"2018","unstructured":"Inamoto T, Matsuyama H, Ibuki N et al (2018) Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study. Ther Adv Urol 10(12):403\u2013410","journal-title":"Ther Adv Urol"},{"key":"3118_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fonc.2019.00157","volume":"9","author":"CC Huang","year":"2019","unstructured":"Huang CC, Su YL, Luo HL et al (2019) Gender is a significant prognostic factor for upper tract urothelial carcinoma: a large hospital-based cancer registry study in an endemic area. Front Oncol 9:157","journal-title":"Front Oncol"},{"issue":"3","key":"3118_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10147-011-0284-5","volume":"17","author":"T Inamoto","year":"2012","unstructured":"Inamoto T, Komura K, Watsuji T, Azuma H (2012) Specific body mass index cut-off value in relation to survival of patients with upper urinary tract urothelial carcinomas. Int J Clin Oncol 17(3):256\u2013262","journal-title":"Int J Clin Oncol"},{"issue":"10","key":"3118_CR21","doi-asserted-by":"publisher","first-page":"e0139624","DOI":"10.1371\/journal.pone.0139624","volume":"10","author":"HC Yeh","year":"2015","unstructured":"Yeh HC, Jan HC, Wu WJ et al (2015) Concurrent preoperative presence of hydronephrosis and flank pain independently predicts worse outcome of upper tract urothelial carcinoma. PLoS ONE 10(10):e0139624","journal-title":"PLoS ONE"},{"issue":"4","key":"3118_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.juro.2017.10.019","volume":"199","author":"T Inamoto","year":"2018","unstructured":"Inamoto T, Matsuyama H, Ibuki N et al (2018) Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy. J Urol 199(4):933\u2013939","journal-title":"J Urol"},{"issue":"1","key":"3118_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.juro.2007.03.033","volume":"178","author":"S Holmang","year":"2007","unstructured":"Holmang S, Lele SM, Johansson SL (2007) Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol 178(1):51\u201356","journal-title":"J Urol"},{"issue":"13","key":"3118_CR24","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/cncr.25050","volume":"116","author":"SF Matin","year":"2010","unstructured":"Matin SF, Margulis V, Kamat A et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116(13):3127\u20133134","journal-title":"Cancer"},{"issue":"12","key":"3118_CR25","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L et al (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794\u20131799","journal-title":"Cancer"},{"issue":"4","key":"3118_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag MG, O'Malley RL, O'Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58(4):581\u2013587","journal-title":"Eur Urol"},{"doi-asserted-by":"crossref","unstructured":"Kim DK, Kim JW, Jung HD, Ahn HK, Lee JY, Cho KS (2019) Effects of adjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. Clin Genitourin Cancer","key":"3118_CR27","DOI":"10.1016\/j.clgc.2019.08.010"},{"issue":"8","key":"3118_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1442-2042.2012.03009.x","volume":"19","author":"T Kondo","year":"2012","unstructured":"Kondo T, Tanabe K (2012) Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int J Urol 19(8):710\u2013721","journal-title":"Int J Urol"},{"issue":"4","key":"3118_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00345-016-1764-z","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Shariat SF, Cussenot O et al (2017) Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 35(4):535\u2013548","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-020-03118-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T23:36:17Z","timestamp":1613691377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-020-03118-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3118"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03118-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"5 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}